Article
Lithium: a key to the genetics of bipolar disorder
1 Jan 2009
Abstract excerpt
Since the 1950s, lithium salts have been the main line of treatment for bipolar disorder (BD), both as a prophylactic and as an episodic treatment agent. Like many psychiatric conditions, BD is genetically and phenotypically heterogeneous, but evidence suggests that individuals who respond well to lithium treatment have more homogeneous clinical and molecular profiles. Response to lithium seems to cluster in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
